Clinical Trial Update: Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating the effects of SGLT2 inhibition on mechanisms of cardiac damage in patients with type 2 diabetes and heart failure with preserved eject…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure with Preserved Ejection Fraction
• Type 2 Diabetes Mellitus

Snippet

Sponsor: Hospital General Universitario Gregorio Marañon | Conditions: Diabetes Mellitus, Type 2, Heart Failure With Preserved Ejection Fraction | Phase 4 | Status: UNKNOWN